官方服务：
资源简介：
Sixteen approved NSCLC drugs.
应用场景：
创建时间：
2017-08-19
相关数据集
Pulmonary Drugs Market Size, Trends and Forecast to 2030
Pulmonary Drugs Market to be valued at $77.31 Bn by 2030. Report: Industry Size, Y-o-Y Growth Rate, Epidemiology, Prevalence Rate
www.coherentmarketinsights.com120
‘Effective’ drugs on SCLC cells.
*overlapping drug between two studies ‘Effective’ drugs on SCLC cells.
NIAID Data Ecosystem90
Semisynthesis and Non-Small-Cell Lung Cancer Cytotoxicity Evaluation of Germacrane-Type Sesquiterpene Lactones from Elephantopus scaber
Two series of germacrane-type sesquiterpene lactones were produced by semisynthetic modulation of scaberol C, which was prepared by a standard chemical transformation from an Elephantopus scaber extra
NIAID Data Ecosystem50
PM01183 and Cisplatin on SCLC cell lines
Small Cell Lung Cancer (SCLC) is an aggressive neuroendocrine malignancy with a poor prognosis. Here, we focus on the neuroendocrine SCLC subtypes SCLC-A and SCLC-N, whose transcription addiction was
NIAID Data Ecosystem110
Table 1_Anticancer activity of RM-3-22: a TAZQ-based hydroxamic acid derivative targeting NSCLC in vitro and in vivo.docx
IntroductionLung cancer remains the leading cause of cancer-related deaths, necessitating novel therapeutic strategies. In this study, we developed RM-3-22, a TAZQ-based hydroxamic acid derivative wit
NIAID Data Ecosystem70
